Artificial Intelligence

Artificial intelligence, or AI, is an umbrella term for machine learning and deep learning. It is where a machine takes in information from its surroundings and, from that, makes the most optimal decision appropriate to the situation.

AI in Food: How Artificial Intelligence is Designing Healthier and More Sustainable Foods

Artificial intelligence is transforming food innovation by accelerating ingredient discovery, optimizing formulations, and enabling personalized nutrition strategies to improve public health outcomes. AI-driven tools also support food safety assessment, sustainable food systems, and precision nutrition while raising important governance, equity, and validation challenges.

Can Artificial Intelligence be used to Diagnose Brain Aneurysms?

The Medical Industries That Are Most Likely to Be Impacted by Ai

AI-Powered Genomic Analysis: Revolutionizing the Detection of Genetic Mutations

Is Data at the Center of Healthcare for the Future?

What does ChatGPT mean for Healthcare?

AI Psychosis: How Artificial Intelligence May Trigger Delusions and Paranoia

Recent Developments in Health Technology

Artificial Intelligence and Deep Learning in Medicine

Uncovering the Mystery of the Human Brain with Computational Neuroscience

Machine Learning in Drug Development

Artificial Intelligence in CBT

See more featured articles »

Ethical Considerations in AI-Driven Healthcare

Applying Deep Learning to Localization Microscopy

Deep-Learning in Radiology

The Role of AI in Pathogen Detection and Epidemic Prediction

The Pros and Cons of Healthcare Chatbots

How Artificial Intelligence Is Revolutionizing Emergency Medicine

Beyond Virtual Consultations: The Rise of AI-Driven Virtual Healthcare Assistants

Artificial Intelligence in Cardiology

Managing the Explosion of Healthcare Data to Harness its Power

Artificial Intelligence and Life Science

Artificial Intelligence in Histopathology

Latest Artificial Intelligence News and Research

Insilico Medicine launches Pharma AI Spring Kickoff 2026 webinar

As the AI era becomes increasingly shaped by foundation models, the pharmaceutical industry is entering a new phase of opportunity for discovery, design, and decision-making driven by AI for science.

10 Apr 2026

New embodied AI system teaches users complex movements via muscles

A new system from Yun Ho, Romain Nith, and Pedro Lopes combines AI and electrical muscle stimulation to physically guide users through unfamiliar tasks—marking a leap toward general-purpose, context-aware embodied assistance.

10 Apr 2026

Dynamic AI models detect body tipping points to forecast disease before symptoms

The editorial, "Dynamics-driven medical big data mining: dynamic approaches to early disease forecasting and individualized care," published in Intelligent Medicine (February 2026, Volume 6, Issue 1), was written by Lu Wang (Tianjin Medical University), Han Lyu (Beijing Friendship Hospital, Capital Medical University), and Bin Sheng (Shanghai Jiao Tong University).

10 Apr 2026

Revvity unveils its Signals BioDesign offering to advance biologic research workflows

Revvity, Inc. announced that its Revvity Signals Software business is launching Signals BioDesign™, a cloud-native molecular cloning solution that streamlines biologics research workflows.

From Revvity Signals Software Inc. 10 Apr 2026

Watch: As AI makes more health coverage decisions, the risks to patients grow

This year, executives from nearly every major health insurance company made the same declaration in calls with Wall Street analysts: Using artificial intelligence to make coverage decisions would help save them money.

10 Apr 2026

Experts call for expanded Medicaid coverage to improve children’s health

As states reassess Medicaid coverage following recent federal policy changes and the end of pandemic-era protections, researchers are advocating for evidence-based health care policy reform and expanded Medicaid coverage for children.

9 Apr 2026

IBS diagnosis gaps persist across racial and gender groups in the U.S.

A national survey study led by UCLA Health and Cedars-Sinai Medical Center found significant disparities in how irritable bowel syndrome, or IBS, is diagnosed across sex and racial groups in the U.S., with men and Black patients considerably less likely than women and white patients to receive a formal diagnosis.

9 Apr 2026

AI-powered chemistry accelerates discovery of selective cancer inhibitors

Recently, the Insilico team's research entitled "An Internal Sulfur-Lone Pair Interaction Enabled the Discovery of Potential and Sub-Family Selective PKMYT1 Inhibitors" was invited for publication as a cover Feature in ChemMedChem.

9 Apr 2026

UVA scientists develop AI tools to accelerate new drug discovery

University of Virginia School of Medicine scientists have developed a bold new approach to drug development and discovery that could dramatically accelerate the creation of new medicines.

9 Apr 2026

Insilico Medicine nominates AI-driven drug candidate for cancer, Cushing's syndrome and obesity

The NR3C1 (nuclear receptor subfamily 3 group C member 1) gene encodes the glucocorticoid receptor (GR), a nuclear receptor vital for maintaining physiological homeostasis, and inhibition of NR3C1 could increase the sensitivity of cancer cells to standard chemotherapy, particularly in ovarian cancer.

8 Apr 2026

Study identifies a common brain activity pattern across psychedelics

Scientists have demonstrated, for the first time, that several psychedelic drugs – including psilocybin, LSD, mescaline, DMT and ayahuasca – produce a common pattern of brain activity despite their distinct chemistries.

8 Apr 2026

ChatGPT delivers clearer PCOS answers than standard resources

ChatGPT outperforms traditional resources in clarity for PCOS information, highlighting its role as a supportive tool in evidence-based healthcare education.

8 Apr 2026

AI models may amplify bias in psychiatric aggression predictions

A first-of-its-kind study led by researchers at the Centre for Addiction and Mental Health (CAMH) has found that artificial intelligence (AI) models used to predict aggressive incidents in acute psychiatric care can reinforce and amplify existing social and structural inequities by overestimating the likelihood of aggression among already marginalized groups.

7 Apr 2026

New blood test spots four cancers and other diseases by stripping away healthy DNA noise

MethylScan is a new low-cost cell-free DNA methylome test that removes much of the healthy blood DNA background, helping rare disease signals stand out more clearly. In more than 1,000 people, it showed strong performance for detecting four cancers, classifying liver diseases, and identifying organ-specific damage.

7 Apr 2026

AI tool predicts Barrett’s esophagus recurrence with high accuracy

A new artificial intelligence (AI)–based tool shows promise for improving surveillance in patients treated with endoscopic eradication therapies for Barrett's esophagus (BE) related dysplasia and early esophageal adenocarcinoma.

7 Apr 2026

Gladstone investigator wins MIND Prize to decode hidden Alzheimer’s genetics

Gladstone Institutes investigator Ryan Corces, PhD, has been named a 2026 winner of the Pershing Square Foundation's MIND Prize, a prestigious award recognizing next-frontier thinkers who are uncovering a deeper understanding of the brain and cognition.

7 Apr 2026

Interpretable machine learning model advances analysis of complex genetic traits

A new study published in Genome Research presents an interpretable artificial intelligence framework that improves both the accuracy and transparency of genomic prediction, a key challenge in fields such as precision medicine, crop science, and animal breeding.

7 Apr 2026

Dual perspective AI model achieves high accuracy in early lung cancer diagnosis

Lung cancer remains the leading cause of cancer-related deaths worldwide, accounting for nearly one in five cancer deaths - around 1.8 million lives lost each year.

7 Apr 2026

Can I opt out of having my doctor take notes with AI?

Family physician Eric Boose has been using an artificial intelligence tool to get back to what he calls "old-fashioned medicine" — talking with patients face-to-face, without having to type into a computer at the same time.

7 Apr 2026

Study explores role of AI automation in psychotherapy practice

Psychotherapy has always been a deeply human endeavor: a patient talking, a therapist listening and responding, and healing happening through words. But with the rapid rise of conversational artificial intelligence, particularly large language models (LLMs), that paradigm is shifting fast.

6 Apr 2026